Company news
OpSens Inc news in 2022
OpSens Inc's news releases, calls and decks from 2022, newest first.
OpSens announces filing of preliminary base shelf prospectus
December 22, 2022
OpSens announces closing of $11.5 million bought deal public offering including $1.5 million over-allotment option exercised in full
December 22, 2022
OpSens Inc. announces $10 million bought deal offering
December 1, 2022
OpSens announces first SavvyWire(tm) procedure in New Zealand
November 29, 2022
OpSens announces fourth quarter and fiscal year 2022 Financial results
November 22, 2022
OpSens to host fourth quarter fiscal year 2022 financial results conference call and year-end update on November 22, 2022
November 16, 2022
OpSens announces departure of CFO
November 1, 2022
OpSens announces first SavvyWire clinical cases in Europe and launch of SAFE-TAVI study
October 26, 2022
OpSens announces first SavvyWire procedure in the United States by Dr. Philippe Genereux of Morristown Medical Center
September 23, 2022
OpSens announces FDA clearance for the SavvyWire(tm) for use in transcatheter aortic valve replacement (TAVR) procedures
September 15, 2022
OpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in Boston September 16-19, 2022
September 14, 2022
OpSens announces third quarter fiscal 2022 financial results with record quarterly revenues
July 14, 2022
OpSens Awarded Interventional Specialty Diagnostics Agreement with Premier for OptoWire III
July 11, 2022
OpSens to host third quarter fiscal year 2022 financial results conference call on Thursday, July 14
July 7, 2022
OpSens announces global SavvyWire(tm) first commercial use
June 7, 2022
OpSens SavvyWire(tm) first-in-human results presented at europcr in paris and simultaneously published in eurointervention journal
May 19, 2022
OpSens announces publication in jscai of data supporting the correlation between the OptoWire and a novel TAVR interface with standard of care, before and after TAVR
May 18, 2022
OpSens announces Health Canada approval for its new TAVR guidewire
April 26, 2022
OpSens announces second quarter fiscal 2022 Financial results
April 13, 2022
OpSens to host second quarter fiscal year 2022 financial results conference call on Wednesday, April 13
April 6, 2022
OpSens to Participate in the 32nd Annual Oppenheimer Healthcare Conference March 15th to 17th
March 14, 2022
OpSens Reports on Voting Results from its Annual Shareholders Meeting
February 25, 2022
OpSens appoints Brad Davis as new chief commercial officer
February 9, 2022
OpSens announces abiomed 4-year supply agreement extension to 2028
February 1, 2022
OpSens named to 2022 OTCQX Best 50
January 24, 2022
OpSens Announces FIRST Quarter fiscal 2022 Financial Results
January 13, 2022
OpSens to host first quarter fiscal year 2022 financial results conference call on Thursday, January 13, 2022
January 6, 2022
Decks in 2022
- Investor Presentation (September 2022)
Investor deck · 41 slides · Sep 29, 2022
- Investor Presentation (April 2022)
Investor deck · 42 slides · Apr 27, 2022